Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.41
+0.09 (0.33%)
At close: Mar 19, 2026, 4:00 PM EDT
27.46
+0.05 (0.18%)
Pre-market: Mar 20, 2026, 4:35 AM EDT

Pfizer Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21
17,55716,65414,65313,71517,76317,70213,28314,87914,56913,49113,00718,48625,13522,63827,74225,66123,83824,03518,89914,516
Revenue Growth (YoY)
-1.16%-5.92%10.31%-7.82%21.92%31.21%2.12%-19.51%-42.04%-40.41%-53.11%-27.96%5.44%-5.81%46.79%76.78%108.61%133.87%91.60%43.96%
Cost of Revenue
5,2724,1723,7782,8455,9095,2633,3003,3797,5639,2693,2374,8869,6486,0638,6489,9849,7369,9326,9964,157
Gross Profit
12,28512,48210,87510,87011,85412,4399,98311,5007,0064,2229,77013,60015,48716,57519,09415,67714,10214,10311,90310,359
Selling, General & Admin
4,1623,1863,4153,0314,2743,2443,7173,4954,5753,2813,4973,4184,6453,3913,0482,5934,1042,8992,9232,777
Depreciation & Amortization Expenses
1,2291,2231,2111,2111,3591,3121,3071,3081,2671,1791,1841,1031,131822822835957968917858
Research & Development
3,4183,9362,4842,2123,1232,6112,7022,4932,8872,7782,6812,5263,6883,2202,8162,6565,9153,4432,4582,013
Other Operating Expenses
5,1188037211,6313,1085562,3617822,407336139284-51140961542-1,046-1,050-1,344-982
Total Operating Expenses
13,9279,1487,8318,08511,8647,72310,0878,07811,1367,5747,5017,3319,4137,5737,6476,6269,9306,2604,9544,666
Operating Income
-1,6423,3343,0442,785-104,716-1043,422-4,130-3,3522,2696,2696,0749,00211,4479,0514,1727,8436,9495,693
Pretax Income
-1,6423,3343,0442,785-104,715-1033,421-4,129-3,3522,2696,2705,2319,00111,4479,0503,8277,8436,9495,692
Provision for Income Taxes
-2-216141-189-421234-134293-795-964-717152303561,5701,172334-3281,123808
Net Income
-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,3938,1465,5634,877
Minority Interest in Earnings
89186887896111381566-212269
Earnings From Discontinued Operations
--25-7-817-5-2612-212-2134-9-186-13-2361
Net Income to Common
-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,3938,1465,5634,877
Net Income Growth
--20.69%6997.56%-4.75%---98.24%-43.80%---76.51%-29.51%47.19%5.67%78.07%61.25%301.06%454.53%59.44%45.37%
Shares Outstanding (Basic)
5,6865,6855,6855,6755,6675,6675,6665,6575,6475,6465,6465,6345,6155,6075,5935,6175,6165,6095,5985,584
Shares Outstanding (Diluted)
5,7225,7145,7065,7105,7035,7055,6965,6975,6475,6465,7135,7275,7435,7185,7125,7585,7685,7255,6785,662
Shares Change (YoY)
0.33%0.16%0.18%0.23%0.99%1.04%-0.30%-0.52%-1.67%-1.26%0.02%-0.54%-0.43%-0.12%0.60%1.70%1.87%1.63%1.05%0.87%
EPS (Basic)
-0.290.620.510.520.070.790.010.55-0.60-0.420.410.980.891.541.771.400.601.451.040.87
EPS (Diluted)
-0.290.620.510.520.070.780.010.55-0.60-0.420.410.970.871.511.731.370.591.421.020.86
EPS Growth
--20.51%5000.00%-5.46%---97.56%-43.30%---76.30%-29.20%47.46%6.34%69.61%59.30%293.33%446.15%64.52%43.33%
Free Cash Flow
4,5034,001-1,2001,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,91210,21110,7623,984
Free Cash Flow Growth
-22.42%-34.01%-358.81%38.32%129.14%-428.77%-44.65%-48.45%--98.76%54.34%-49.73%-31.06%48.04%1.49%545.04%247.39%48.44%
Free Cash Flow Per Share
0.790.70-0.210.311.021.06-0.420.070.740.47-0.370.011.320.901.301.020.851.781.900.70
Dividends Per Share
0.8600.4300.4300.4300.8400.4200.4200.4200.4100.4100.4100.4100.4000.4000.4000.4000.3900.3900.3900.390
Dividend Growth
2.38%2.38%2.38%2.38%104.88%2.44%2.44%2.44%2.50%2.50%2.50%2.50%2.56%2.56%2.56%2.56%2.63%2.63%2.63%2.63%
Gross Margin
69.97%74.95%74.22%79.26%66.73%70.27%75.16%77.29%48.09%31.29%75.11%73.57%61.62%73.22%68.83%61.09%59.16%58.68%62.98%71.36%
Operating Margin
-9.35%20.02%20.77%20.31%-0.06%26.64%-0.78%23.00%-28.35%-24.85%17.44%33.91%24.17%39.76%41.26%35.27%17.50%32.63%36.77%39.22%
Profit Margin
-9.34%21.32%19.81%21.68%2.31%25.31%0.23%21.02%-22.89%-17.70%17.99%30.05%19.90%38.19%35.60%30.70%15.01%34.00%30.82%33.65%
FCF Margin
25.65%24.02%-8.19%12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.39%30.16%22.67%26.74%22.98%20.61%42.48%56.94%27.45%
EBITDA
454,9964,6694,4031,7816,4711,6275,158-2,460-1,7923,8427,7567,59310,18512,62210,2385,5079,1848,2576,900
EBITDA Margin
0.26%30.00%31.86%32.10%10.03%36.56%12.25%34.67%-16.89%-13.28%29.54%41.96%30.21%44.99%45.50%39.90%23.10%38.21%43.69%47.53%
EBIT
-1,6423,3343,0442,785-104,716-1043,422-4,130-3,3522,2696,2696,0749,00211,4479,0514,1727,8436,9495,693
EBIT Margin
-9.35%20.02%20.77%20.31%-0.06%26.64%-0.78%23.00%-28.35%-24.85%17.44%33.91%24.17%39.76%41.26%35.27%17.50%32.63%36.77%39.22%
Effective Tax Rate
0.12%-6.48%4.63%-6.79%4210.00%4.96%130.10%8.56%19.25%28.76%-3.13%11.40%4.40%3.96%13.72%12.95%8.73%-4.18%16.16%14.20%
Updated Feb 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q